Stock Scorecard
Stock Summary for Johnson & Johnson (JNJ) - $190.85 as of 10/14/2025 8:33:00 PM EST
Total Score
11 out of 30
Safety Score
75 out of 100
Currently on the following lists
None
Tim's Recommendation
Possible Buy
Growth List Algorithm Criteria for JNJ
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for JNJ
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for JNJ
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for JNJ
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for JNJ (75 out of 100)
| Stock Price Rating (Max of 10) | 10 |
| Historical Stock Price Rating (Max of 10) | 10 |
| Stock Price Trend (Max of 10) | 9 |
| Book Value (Max of 10) | 8 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 4 |
| Dividend Yield Percentage (Max of 10) | 6 |
| Operating Margin (Max of 10) | 5 |
| Trading Volume (Max of 10) | 10 |
| Price to Earnings (Max of 10) | 8 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for JNJ
Financial Details for JNJ
Company Overview |
|
|---|---|
| Ticker | JNJ |
| Company Name | Johnson & Johnson |
| Country | USA |
| Description | Johnson & Johnson (JNJ) is a leading American multinational corporation established in 1886, specializing in the development and manufacturing of healthcare products across three segments: medical devices, pharmaceuticals, and consumer health products. With a strong reputation for innovation and quality, J&J is a key player in the global healthcare market and is recognized as one of the world's most valuable companies. As a component of the Dow Jones Industrial Average, the company holds a premier AAA credit rating, reflecting its financial stability and strong operational performance. Ranked No. 36 on the Fortune 500 list, J&J continues to leverage its extensive portfolio to drive sustainable growth and enhance its position as a trusted provider of health solutions. |
| Sector Name | HEALTHCARE |
| Industry Name | DRUG MANUFACTURERS - GENERAL |
| Most Recent Quarter | 6/30/2025 |
| Next Earnings Date | 10/14/2025 |
Stock Price History |
|
| Last Day Price | 190.85 |
| Price 4 Years Ago | 153.17 |
| Last Day Price Updated | 10/14/2025 8:33:00 PM EST |
| Last Day Volume | 13,531,067 |
| Average Daily Volume | 8,494,895 |
| 52-Week High | 192.10 |
| 52-Week Low | 137.37 |
| Last Price to 52 Week Low | 38.93% |
Valuation Measures |
|
| Trailing PE | 20.40 |
| Industry PE | 25.72 |
| Sector PE | 40.41 |
| 5-Year Average PE | 18.69 |
| Free Cash Flow Ratio | 24.75 |
| Industry Free Cash Flow Ratio | 37.88 |
| Sector Free Cash Flow Ratio | 29.23 |
| Current Ratio Most Recent Quarter | 1.01 |
| Total Cash Per Share | 7.71 |
| Book Value Per Share Most Recent Quarter | 32.60 |
| Price to Book Ratio | 5.71 |
| Industry Price to Book Ratio | 10.65 |
| Sector Price to Book Ratio | 32.01 |
| Price to Sales Ratio Twelve Trailing Months | 5.07 |
| Industry Price to Sales Ratio Twelve Trailing Months | 3.88 |
| Sector Price to Sales Ratio Twelve Trailing Months | 15.78 |
| Analyst Buy Ratings | 9 |
| Analyst Strong Buy Ratings | 2 |
Share Statistics |
|
| Total Shares Outstanding | 2,408,339,000 |
| Market Capitalization | 459,631,498,150 |
| Institutional Ownership | 74.42% |
Dividends |
|
| Ex-Dividend Date | 8/26/2025 |
| Previous Dividend Amount | 1.3000 |
| Current Dividend Amount | 1.3000 |
| Total Years Dividend Increasing |
|
| Trailing Annual Dividend Rate | 5.08 |
| Trailing Annual Dividend Yield | 2.66% |
| Forward Annual Dividend Rate | 5.20 |
| Forward Annual Dividend Yield | 2.73% |
| 5-Year Dividend Payments Count | 20 |
| 3-Year Average Dividend Yield | 3.48% |
| 5-Year Average Dividend Yield | 3.03% |
| 1-Year Dividend Growth Rate Percentage | 5.91% |
| 3-Year Dividend Growth Rate Percentage | 2.91% |
| 5-Year Dividend Growth Rate Percentage | 5.55% |
| All-Time Dividend Growth Rate Percentage | 13.03% |
| Dividend Payout Ratio | 54.33% |
Income Statement |
|
| Quarterly Earnings Growth YOY | 18.70% |
| Annual Earnings Growth | -59.99% |
| Reported EPS 12 Trailing Months | 9.35 |
| Reported EPS Past Year | 5.54 |
| Reported EPS Prior Year | 9.99 |
| Net Income Twelve Trailing Months | 22,661,000,000 |
| Net Income Past Year | 14,066,000,000 |
| Net Income Prior Year | 35,153,000,000 |
| Quarterly Revenue Growth YOY | 5.80% |
| 5-Year Revenue Growth | 1.60% |
| Operating Margin Twelve Trailing Months | 28.90% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 18,577,000,000 |
| Total Cash Past Year | 24,105,000,000 |
| Total Cash Prior Year | 21,859,000,000 |
| Net Cash Position Most Recent Quarter | -20,658,000,000 |
| Net Cash Position Past Year | -6,546,000,000 |
| Long Term Debt Past Year | 30,651,000,000 |
| Long Term Debt Prior Year | 25,881,000,000 |
| Total Debt Most Recent Quarter | 39,235,000,000 |
| Equity to Debt Ratio Past Year | 0.70 |
| Equity to Debt Ratio Most Recent Quarter | 0.67 |
| Total Stockholder Equity Past Year | 71,490,000,000 |
| Total Stockholder Equity Prior Year | 68,774,000,000 |
| Total Stockholder Equity Most Recent Quarter | 78,473,000,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 16,397,000,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 6.81 |
| Free Cash Flow Past Year | 19,842,000,000 |
| Free Cash Flow Prior Year | 18,248,000,000 |
Options |
|
| Put/Call Ratio | 0.47 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 3.93 |
| MACD Signal | 3.11 |
| 20-Day Bollinger Lower Band | 143.98 |
| 20-Day Bollinger Middle Band | 170.07 |
| 20-Day Bollinger Upper Band | 196.15 |
| Beta | 0.39 |
| RSI | 66.16 |
| 50-Day SMA | 157.72 |
| 150-Day SMA | 152.76 |
| 200-Day SMA | 153.46 |
System |
|
| Modified | 10/14/2025 2:32:39 AM EST |